Skip to content

[OCT Article] Unraveling Green Disease with the Optovue Solix AngioVue Disc Report

The Optovue Solix Disc Combo Report provides detailed insights into optic nerve evaluation, revealing subtle findings crucial for diagnosing and managing glaucoma. This text emphasizes the importance of utilizing advanced analysis, such as vessel density assessment and extended GCC analysis, to accurately assess disease progression and guide treatment decisions, particularly in cases of severe vision loss where conventional tests may fall short.

[OCT Article] Unraveling Green Disease with the Optovue Solix AngioVue Disc Report Image

Patient description

The presenting patient is a 61-year-old white female with severe normal tension glaucoma in both eyes. The 30-2 Octopus Visual fields below (Figure 1) show a shallow paracentral scotoma in the right eye and nasal step in the left eye. The field depression is near 10° within fixation on the left eye and a dense, larger paracentral scotoma is within 5° in the right eye on the macular visual field analysis.

Clinical results

Evaluating the optic nerve with the Optovue Solix Disc Combo Report 9 (Figure 2), the right eye has green disease of the retinal nerve fiber layer (RNFL) due to normal appearance of NFL on statistical analysis. However, the ganglion cell complex (GCC) thickness report (Figure 3) shows the extended view of NFL thinning extending from the optic nerve, which is consistent with the macular visual field loss. Evaluating the AngioVue Disc report of the right eye, the thinning of the vessel density correlating to the NFL wedge defects inferior and superior temporally can be appreciated especially at the radial peripapillary capillary (RPC) and superficial layers. Examining the en face AngioVue Disc also shows the correlating NFL wedge defects. The left eye has a similar appearance, but does not have green disease and displays the thinning of the NFL thickness that correlates with the field loss.

Using the Optovue Solix AngioVue report and evaluating the vessel density loss, as well as the en face and extended GCC analysis, can help rule out green disease, especially when the patient has severe vision loss that may be missed with conventional OCT analysis reports and 30-2 visual field testing. This information is essential when determining the stage of glaucoma and how aggressive treatment needs to be to prevent further central vision loss.

Figure 1.

Disc combo analysis

Figure 2.

Left eye AngioVue analysis RPC layer

Right eye AngioVue analysis RPC layer

Left eye NFL Thickness Analysis

Right eye NFL Thickness Analysis

Right eye AngioVue Analysis Retinal Layer

Right Eye AngioVue Anaylsis Superficial Layer

Figure 3.

 


Dr Holly TernusHolly Ternus, OD, FAAO, FSLS 
Owner of Heartland Eye Consultants in Omaha, NE.

 

 

The information is intended for general informational purposes only. It is not intended as, and should not be considered, a substitute for professional medical advice, diagnosis, or treatment.
The content is not designed to replace the relationship that exists between a patient and their healthcare provider. Any medical decisions should be made in consultation with a qualified healthcare professional who can provide information tailored to your individual circumstances.
Medical procedures, case studies, and practices mentioned in this content may vary based on regional standards, local regulations, and the discretion of the providing healthcare professional. What may be considered appropriate and ethical in one country may differ in another.
The content may include general references to medical practices, medications, or treatments that are widely accepted in certain regions but may not be applicable or endorsed universally. It is important to consult with a healthcare professional in your jurisdiction to ensure the information is relevant to your specific situation.
The authors, publishers, and contributors of this content disclaim any liability for any adverse effects resulting directly or indirectly from information contained in this content. Readers should exercise their own judgment and seek the advice of healthcare professionals as appropriate.
By accessing and using this content, you acknowledge and agree to the terms of this disclaimer.

Learn more about our OCT